Your browser doesn't support javascript.
loading
Corrigendum to "Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models".
Zhang, Qing; Zhang, Haixu; Ding, Jiage; Liu, Hongyan; Li, Huizhong; Li, Hailong; Lu, Mengmeng; Miao, Yangna; Li, Liantao; Zheng, Junnian.
Afiliação
  • Zhang Q; Cancer Institute, Xuzhou Medical University, Xuzhou, Jiangsu 221002, China.
  • Zhang H; Cancer Institute, Xuzhou Medical University, Xuzhou, Jiangsu 221002, China.
  • Ding J; The Affiliated Aoyang Hospital of Jiangsu University, Zhangjiagang, Jiangsu 215600, China.
  • Liu H; Cancer Institute, Xuzhou Medical University, Xuzhou, Jiangsu 221002, China.
  • Li H; Cancer Institute, Xuzhou Medical University, Xuzhou, Jiangsu 221002, China.
  • Li H; Cancer Institute, Xuzhou Medical University, Xuzhou, Jiangsu 221002, China.
  • Lu M; Cancer Institute, Xuzhou Medical University, Xuzhou, Jiangsu 221002, China.
  • Miao Y; Cancer Institute, Xuzhou Medical University, Xuzhou, Jiangsu 221002, China.
  • Li L; Cancer Institute, Xuzhou Medical University, Xuzhou, Jiangsu 221002, China.
  • Zheng J; Cancer Institute, Xuzhou Medical University, Xuzhou, Jiangsu 221002, China.
J Immunol Res ; 2019: 2070562, 2019.
Article em En | MEDLINE | ID: mdl-31032372
ABSTRACT
[This corrects the article DOI 10.1155/2018/4263520.].
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: J Immunol Res Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: J Immunol Res Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China